Analysis of the assortment of antidiabetic drugs at the pharmaceutical market of Ukraine
DOI:
https://doi.org/10.24959/nphj.15.2017Keywords:
diabetes, drugs, assortment, marketing research, pharmaceutical marketAbstract
The marketing research of antidiabetic drugs presented at the pharmaceutical market of Ukraine has been conducted. The product range of the group of antidiabetic drugs has been studied according to the ATC classification, manufacturing countries and dosage forms. According to the results of the analysis 49 drugs based on insulin and its analogues for injection, and 157 oral hypoglycemic drugs have been characterized. It is noted that insulins are unevenly divided by the duration of action. Most insulin drugs are presented by human insulin. Oral hypoglycemic drugs are characterized by a high saturation within subgroups. Drugs of aldose reductase inhibitors (Isodibut under the trade name Isodibut®) and other medicines, including 8 herbal medicines, are also used for treatment of diabetes. It has been found that 68% of antidiabetic drugs are imported from 21 countries of the Eurasian and South American continents. India occupies the leading positions. A wide range of antidiabetic drugs is presented by Germany, Poland, France, Denmark and Italy. The range of domestic drugs for treating diabetes is formed by 12 manufacturers. Domestic manufacturers offer only generic replacement of some active substances. At the pharmaceutical market of Ukraine antidiabetic drugs are available in the form of tablets, granules, powders, solutions and suspensions for injection. The research performed has shown that the market of antidiabetic drugs is characterized by heterogeneity of product groups, high concentration and monopolization of production, low competition and a small share of production of drugs attributable to domestic producers.
References
Державний реєстр лікарських засобів України – [Електронний ресурс]. – Режим доступу: http://www.drlz.kiev.ua. – Назва з екрану.
Кирсанов Д. // Еженедельник «Аптека». – 2013. – № 50 (921). – С. 18-19.
Компендиум 2011– лекарственные препараты / Под ред. В.Н.Коваленко, А. П. Викторова. – К.: Морион, 2011. – 2320 с.
Ларін О. С. // Міжнародний ендокринологічний журнал. – 2011. – № 3 (35). – С. 10-19.
Паньків В.І. // Международный эндокринологический журнал. – 2013. – № 7 (55). – С. 95-104.
Beagley J., Guariguata L., Weil C. et al // Diabetes Res Clin Pract – 2014. – Vol. 103, Issue 2. – P. 150-160.
Conway B.N., May M.E., Fischl A. et al // Diabet Med. – 2015. – Vol. 32(1). – P. 33-41.
Blackwell Publishing Ltd // Diabet Med. – 2010. – Vol. 27. – Р. 318-326.
Danaei G., Finucane M.M., Lu Y. et al. // Lancet, 2011. – 378 (9785) – P. 31-40.
Frandsen C.S., Madsbad S. // Diabet Med. – 2014. – Vol. 31(11). – P. 1293-1300.
Global status report on noncommunicable diseases 2010. / Editor Ala Alwan. – Geneva: World Health Organization, 2011. – 176 p.
IDF. Diabetes atlasidf diabetes atlas. Sixth edition // International Diabetes Federation – 2013. – 160 p.
Mathers C.D., Loncar D. // PLoS Med. – 2006. – Vol. 3 (11). – Р. 442.
Moses R.G., Bartley P., Lunt H. et al // Diabetic Med. – 2009. – Vol. 26, Issue 3. – P. 260-267.
Turner K.M., Percival J., Dunger D.B. et al // Diabet Med. – 2015. – Vol. 32(2). – Р. 250-256.
Downloads
Published
Issue
Section
License
Copyright (c) 2015 National University of Pharmacy
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
